Catalyst Biosciences, Inc. (CBIO): Stock Offering News

CBIO – Prices an underwritten public offering of 2,941,176 shares of its common stock at $34.00/share.


Key Facts Surrounding This News Item


  • CBIO had a POWR Rating of A (Strong Buy) coming into today.
  • CBIO was 31.30% above its 10-Day Moving Average coming into today.
  • CBIO was 47.72% above its 20-Day Moving Average coming into today.
  • CBIO was 115.99% above its 50-Day Moving Average coming into today.
  • CBIO was 228.98% above its 100-Day Moving Average coming into today.
  • CBIO was 377.11% above its 200-Day Moving Average coming into today.
  • CBIO had returned +161.00% year-to-date leading up to today’s news, versus a -0.57% return from the benchmark S&P 500 during the same period.

More Info About Catalyst Biosciences, Inc. (CBIO)


Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on engineering proteases as therapeutics for hemophilia, hemeostasis, complement-mediated diseases, and other unmet medical needs. The company is based in South San Francisco, California. View our full CBIO ticker page with ratings, news, and more.

CBIO at a Glance

CBIO Current POWR Rating™
Overall POWR Rating™
CBIO Current Price $7.94 0.13%
More CBIO Ratings, Data, and News

CBIO Price Reaction

The day of this event (Feb. 13, 2018)
CBIO Closing Price$34.36 3.48%
CBIO Volume1,686,400
233.30% from avg
Leading up to this event
CBIO 1-mo returnN/A%
After this event
CBIO 1-day return5.26%
CBIO 3-day return14.54%
CBIO 5-day return29.27%

CBIO Price Chart


The Top Stocks For 2019

More Catalyst Biosciences, Inc. (CBIO) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All CBIO News
Page generated in 0.9078 seconds.